Strength Training and Resveratrol
Launched by TEXAS TECH UNIVERSITY · Sep 3, 2024
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This clinical trial, titled "Strength Training and Resveratrol," is exploring whether a supplement called resveratrol can help older adults (aged 60 and above) get stronger when they do strength training exercises. The study aims to see if taking resveratrol can enhance muscle growth and also improve blood vessel and brain function during and after exercising. Researchers will look at how resveratrol affects tiny particles in the body that help communicate between organs, as this might shed light on how the body responds to strength training.
To join the study, participants must be at least 60 years old, not very active (doing less than one hour of structured exercise each week besides walking), and have not done any strength training in the last six months. They should also not be taking resveratrol supplements currently. The study is not open for recruitment yet, but once it starts, participants can expect to engage in strength training sessions and take the resveratrol supplement, while being monitored for their overall health and progress. It's important for potential participants to be in stable health, without serious medical conditions that could make exercise risky, and to avoid certain substances like cannabis or excessive alcohol.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 60+
- • Minimally active (less than 1 hour of structured exercise/week other than walking)
- • No resistance training for the previous 6 months
- • Not currently taking resveratrol supplements
- • Stable medication, supplement, dietary, and physical activity regimens for the previous 3 months and no plans to change throughout the study period
- • Body mass at least 110 lbs
- Exclusion Criteria:
- • Medical complications that could increase risk during exercise (e.g., cardiovascular disease, uncontrolled hypertension, type 1 or 2 diabetes, orthopedic contraindication to exercise, kidney disease, etc.)
- • Cannabis or nicotine use
- • Consume more than 7 alcohol-containing beverages per week
About Texas Tech University
Texas Tech University, a distinguished research institution located in Lubbock, Texas, is committed to advancing medical knowledge and improving patient care through innovative clinical trials. With a focus on multidisciplinary collaboration and rigorous scientific methodology, Texas Tech University conducts a variety of studies aimed at exploring new treatments, enhancing health outcomes, and addressing pressing healthcare challenges. The university's experienced faculty and state-of-the-art facilities ensure high standards of research integrity and participant safety, making it a trusted sponsor in the field of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lubbock, Texas, United States
Patients applied
Trial Officials
Danielle E Levitt, PhD
Principal Investigator
Texas Tech University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported